Literature DB >> 2449171

The autoactivation of factor XII (Hageman factor) induced by low-Mr heparin and dextran sulphate. The effect of the Mr of the activating polyanion.

M Silverberg1, S V Diehl.   

Abstract

Human Factor XII is known to undergo autoactivation in the presence of dextran sulphate of Mr 500,000. We have now studied the dependence of this reaction on the Mr of the dextran sulphate by using fractions resolved by gel filtration. We have found that autoactivation can be induced by dextran sulphate fractions with Mr as low as 3000, and there is a marked dependence of the rate constant of autoactivation on the Mr value. Fractions with Mr below 8000 gave very low rates of autoactivation; there was a sharp increase in the rate obtained when the Mr of the dextran sulphate was greater than 10,000. Various preparations of heparin were also able to support the autoactivation of Factor XII and gave a very similar relationship between molecular size and reaction rate. The data provide support for the hypothesis that the mechanism by which the 'surface' acts in contact activation involves the presence, on the same particle, of multiple binding sites for the proteins.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2449171      PMCID: PMC1148608          DOI: 10.1042/bj2480715

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  23 in total

1.  Glass surface and blood coagulation.

Authors:  J MARGOLIS
Journal:  Nature       Date:  1956-10-13       Impact factor: 49.962

2.  Dextran sulphate--a synthetic analogue of heparin.

Authors:  C R RICKETTS
Journal:  Biochem J       Date:  1952-04       Impact factor: 3.857

3.  Dermatan sulfate and chondroitin 6-sulfate conformations.

Authors:  S Arnott; J M Guss; D W Hukins; M B Matthews
Journal:  Biochem Biophys Res Commun       Date:  1973-10-15       Impact factor: 3.575

4.  Generation of kinin-like agents by chondroitin sulfate, heparin, chitin sulfate, and human articular cartilage: possible pathophysiologic implications.

Authors:  R W Moskowitz; H J Schwartz; B Michel; O D Ratnoff; T Astrup
Journal:  J Lab Clin Med       Date:  1970-11

5.  Kinetics of activation and autoactivation of human factor XII.

Authors:  D L Tankersley; J S Finlayson
Journal:  Biochemistry       Date:  1984-01-17       Impact factor: 3.162

6.  Enzymatic activities of activated and zymogen forms of human Hageman factor (factor XII).

Authors:  M Silverberg; A P Kaplan
Journal:  Blood       Date:  1982-07       Impact factor: 22.113

7.  Activation of intrinsic blood coagulation by ellagic acid: insoluble ellagic acid-metal ion complexes are the activating species.

Authors:  P E Bock; K R Srinivasan; J D Shore
Journal:  Biochemistry       Date:  1981-12-08       Impact factor: 3.162

8.  Binding and activation properties of human factor XII, prekallikrein, and derived peptides with acidic lipid vesicles.

Authors:  M A Griep; K Fujikawa; G L Nelsestuen
Journal:  Biochemistry       Date:  1985-07-16       Impact factor: 3.162

9.  Role of surface in surface-dependent activation of Hageman factor (blood coagulation factor XII).

Authors:  J H Griffin
Journal:  Proc Natl Acad Sci U S A       Date:  1978-04       Impact factor: 11.205

10.  The conformation of the mucopolysaccharides. Hyaluronates.

Authors:  E D Atkins; C F Phelps; J K Sheehan
Journal:  Biochem J       Date:  1972-08       Impact factor: 3.857

View more
  10 in total

Review 1.  Kallikreins and kinins: mediators in inflammatory joint disease?

Authors:  K Worthy; C D Figueroa; P A Dieppe; K D Bhoola
Journal:  Int J Exp Pathol       Date:  1990-08       Impact factor: 1.925

2.  Host Pathways of Hemostasis that Regulate Group A Streptococcus pyogenes Pathogenicity.

Authors:  Victoria A Ploplis; Francis J Castellino
Journal:  Curr Drug Targets       Date:  2020       Impact factor: 3.465

Review 3.  Bradykinin formation. Plasma and tissue pathways and cellular interactions.

Authors:  A P Kaplan; K Joseph; Y Shibayama; Y Nakazawa; B Ghebrehiwet; S Reddigari; M Silverberg
Journal:  Clin Rev Allergy Immunol       Date:  1998       Impact factor: 8.667

Review 4.  The initiation and effects of plasma contact activation: an overview.

Authors:  Lisha Lin; Mingyi Wu; Jinhua Zhao
Journal:  Int J Hematol       Date:  2016-11-15       Impact factor: 2.490

5.  Effect of icatibant, a bradykinin B2 receptor antagonist, on the development of experimental ulcerative colitis in mice.

Authors:  Y Arai; H Takanashi; H Kitagawa; K J Wirth; I Okayasu
Journal:  Dig Dis Sci       Date:  1999-04       Impact factor: 3.199

6.  Activation of the factor XII-driven contact system in Alzheimer's disease patient and mouse model plasma.

Authors:  Daria Zamolodchikov; Zu-Lin Chen; Brooke A Conti; Thomas Renné; Sidney Strickland
Journal:  Proc Natl Acad Sci U S A       Date:  2015-03-16       Impact factor: 11.205

Review 7.  How it all starts: Initiation of the clotting cascade.

Authors:  Stephanie A Smith; Richard J Travers; James H Morrissey
Journal:  Crit Rev Biochem Mol Biol       Date:  2015-05-28       Impact factor: 8.250

8.  Size-controlled synthesis of granular polyphosphate nanoparticles at physiologic salt concentrations for blood clotting.

Authors:  Alexander J Donovan; Joseph Kalkowski; Stephanie A Smith; James H Morrissey; Ying Liu
Journal:  Biomacromolecules       Date:  2014-10-07       Impact factor: 6.988

9.  Contaminated heparin associated with adverse clinical events and activation of the contact system.

Authors:  Takashi Kei Kishimoto; Karthik Viswanathan; Tanmoy Ganguly; Subbiah Elankumaran; Sean Smith; Kevin Pelzer; Jonathan C Lansing; Nammalwar Sriranganathan; Ganlin Zhao; Zoya Galcheva-Gargova; Ali Al-Hakim; Gregory Scott Bailey; Blair Fraser; Sucharita Roy; Thomas Rogers-Cotrone; Lucinda Buhse; Mark Whary; James Fox; Moheb Nasr; Gerald J Dal Pan; Zachary Shriver; Robert S Langer; Ganesh Venkataraman; K Frank Austen; Janet Woodcock; Ram Sasisekharan
Journal:  N Engl J Med       Date:  2008-04-23       Impact factor: 91.245

10.  Regulation of Complement and Contact System Activation via C1 Inhibitor Potentiation and Factor XIIa Activity Modulation by Sulfated Glycans - Structure-Activity Relationships.

Authors:  Ann-Kathrin Schoenfeld; Eric Lahrsen; Susanne Alban
Journal:  PLoS One       Date:  2016-10-26       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.